Company / Interest Expense per Share
Vera Therapeutics, Inc. Interest Expense per Share History
FY2020-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.09
FY2023
5-year range
$0.00 / $0.09
FY2020-FY2023
Trend
+137.4%
vs FY2022
Sector context
#26 of 43
Health Care
What the data says
At $0.09, Vera Therapeutics, Inc.'s interest expense per share ranks #18 of 43 in the Health Care sector. Increased from $0.00 to $0.09 over the past 2 years.
Based on SEC 10-K filings.
0.09 in FY2023 with a 3-year CAGR of -44.5%.
Increased from $0.00 to $0.09 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -44.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $0.09 Sector average $18.61
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 137.4% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.09 | +137.4% |
| FY2022 | $0.04 | +2408.1% |
| FY2021 | $0.00 | -99.7% |
| FY2020 | $0.52 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026